Neurogene Inc.

NGNE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$136,586$148,210$82,021$70,544
Short-Term Investments$175,819$48,947$0$0
Receivables$648$600$0$790
Inventory$0$0$0$1,913
Other Curr. Assets$2,870$2,591$2,698$711
Total Curr. Assets$315,923$200,348$84,719$73,958
Property Plant & Equip (Net)$18,493$20,953$24,546$27,529
Goodwill$0$0$0$0
Intangibles$0$0$0$128
Long-Term Investments$0$0$0$878
Tax Assets$0$0$0$0
Other NC Assets$1,314$1,272$0-$1,006
Total NC Assets$19,807$22,225$24,546$27,529
Other Assets$0$0$0$0
Total Assets$335,730$222,573$109,265$101,487
Liabilities
Payables$1,336$2,596$625$5,630
Short-Term Debt$2,999$2,882$702$1,831
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,822$17,495$5,324$3,395
Total Curr. Liab.$15,157$22,973$6,651$10,856
LT Debt$9,429$13,373$3,987$4,599
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$769$203$0$177,907
Total NC Liab.$10,198$13,576$3,987$182,506
Other Liabilities$0$0$0$0
Cap. Leases$9,429$16,255$4,689$5,209
Total Liabilities$25,355$36,549$10,638$193,362
Equity
Pref Stock$0$0$244,366$0
Common Stock$0$0$0$1
Retained Earnings-$262,298-$187,154-$150,837-$95,648
AOCI$0$0-$0$0
Other Equity$572,673$373,178$5,098$3,772
Total Equity$310,375$186,024$98,627-$91,875
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$335,730$222,573$109,265$101,487
Net Debt-$124,158-$131,955-$77,332-$64,114